Products Affected - Description

• • Diazepam injection, DASH Pharmaceuticals, LLC, 5 mg/mL, 2 mL Luer Lock syringe, 10 count, NDC 69339-0136-34
  • Diazepam injection, Fresenius Kabi, 5 mg/mL, 2 mL Simplist Carpuject syringe, 24 count, NDC 76045-0204-20
  • Diazepam injection, Hikma, 5 mg/mL, 10 mL vial, 10 count, NDC 00641-6243-10
  • Diazepam injection, Hikma, 5 mg/mL, 2 mL vial, 10 count, NDC 00641-6244-10
  • Diazepam injection, Pfizer, 5 mg/mL, 2 mL Carpuject syringe, 10 count, NDC 00409-1273-32

Reason for the Shortage

• • DASH has diazepam injection on shortage due to increased demand.
  • Fresenius Kabi did not provide a reason for the shortage.
  • Hikma did not provide a reason for the shortage.
  • Pfizer diazepam injection on shortage due to increased demand.

Available Products

• • Diazepam injection, DASH Pharmaceuticals, LLC, 5 mg/mL, 10 mL vial, 5 count, NDC 69339-0137-05
  • Diazepam injection, Pfizer, 5 mg/mL, 10 mL vial, 10 count, NDC 00409-3213-12

• • DASH has diazepam 5 mg/mL 2 mL syringes on back order and the company estimates a release date of July 2024.
  • Fresenius Kabi has diazepam 5 mg/mL Simplist 2 mL syringes on back order and the company cannot estimate a release date. Check wholesalers for availability.
  • Hikma has diazepam 5 mg/mL 2 mL vials on allocation. The 10 mL vials are on back order and the company cannot estimate a release date.
  • Pfizer has diazepam 5 mg/mL Carpuject 2 mL syringes on back order and the company estimates a release date of August 2024.